AEF:CA:TSX-Apollo Healthcare Corp (CAD)

COMMON STOCK | Household & Personal Products | TSX

Last Closing Price

CAD 2.19

Change

0.00 (0.00)%

Market Cap

CAD 0.16B

Volume

0.05M

Avg Analyst Target

N/A

Avg User Target

CAD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Acasta Enterprises Inc. is a private equity firm specializing in buyouts. It prefer to invest in founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented businesses. The firm prefers to invest in private label consumer staples and aviation finance and asset management companies. It prefer to have majority stake in companies. Acasta Enterprises Inc. was founded in 2015 and is based in Toronto, Canada.

Company Website : http://www.acastaenterprises.com/

Address : 1 Apollo Place, Toronto, ON, Canada, M3J 0H2

Employees : 420

Fiscal Year End : December

Currency: CAD

Country : Canada

Technical Indicators

Beta : 1.17

52 Week High : 3.88

Short Ratio : 5.97

52 Week Low : 3.02

Shorted Shares : 135,495

200 Day Moving Average : 2.23

Shorted Shares Previous Month : 6,592

50 Day Moving Average : 4.02

Shares Held By Insiders : 42.66%

Shares Held by Institutions : 17.63%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-20 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AHC:CA Apollo Healthcare Corp

-0.04 (-1.96%)

 CAD0.15B 2.16 1.49
KPT:CA KP Tissue Inc

+0.03 (+0.29%)

 CAD0.10B 145.73 N/A
MAV:CA MAV Beauty Brands Inc

-0.09 (-4.13%)

 CAD0.08B 7.80 11.15

ETFs Containing AEF:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 40.43% N/A N/A 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.43% N/A N/A 2% F
Risk Return Profile  
Volatility (Standard Deviation) 168.31% N/A N/A 14% F
Risk Adjusted Return 24.02% N/A N/A 5% F
Market Capitalization 0.16B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 6.56 N/A N/A N/A N/A
Price/Book Ratio 4.84 N/A N/A N/A N/A
Price / Cash Flow Ratio 33.10 N/A N/A N/A N/A
EV/EBITDA 5.55 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -1.90% N/A N/A N/A N/A
Return on Assets 12.03% N/A N/A N/A N/A
Debt to Equity Ratio 177.16% N/A N/A N/A N/A
Technical Ratios  
Short Ratio 5.97 N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.17 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike